HomeAIM • NYSEAMERICAN
add
AIM ImmunoTech Inc
$0.55
Pre-market:(0.84%)-0.0046
$0.55
Closed: Apr 2, 6:07:56 AM GMT-4 · USD · NYSEAMERICAN · Disclaimer
Previous close
$0.59
Day range
$0.55 - $0.60
Year range
$0.53 - $38.68
Market cap
4.44M USD
Avg Volume
6.69M
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 21.00K | -53.33% |
Operating expense | 2.93M | -50.23% |
Net income | -4.18M | 30.03% |
Net profit margin | -19.88K | -49.93% |
Earnings per share | -0.44 | 95.60% |
EBITDA | -2.91M | 49.77% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.05M | -23.38% |
Total assets | 5.78M | -32.83% |
Total liabilities | 15.56M | 56.75% |
Total equity | -9.78M | — |
Shares outstanding | 8.15M | — |
Price to book | -0.18 | — |
Return on assets | -130.90% | — |
Return on capital | 171.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.18M | 30.03% |
Cash from operations | -1.99M | 49.79% |
Cash from investing | -95.00K | -102.56% |
Cash from financing | 2.72M | 162.20% |
Net change in cash | 638.00K | -18.83% |
Free cash flow | -1.43M | 74.40% |
About
AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees.
The company has created an immunomodulatory double stranded RNA drug called Ampligen.
It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome. Wikipedia
Founded
1966
Headquarters
Website
Employees
22
